Pulmonary IgG4-related disease with favourable response to rituximab: A case report

Romain Muller1, Mikael Ebbo1, Paul Habert2

  • 1Internal Medicine Department Hopital La Timone, APHM, Aix Marseille University Marseille France.

Respirology Case Reports
|November 4, 2022
PubMed

Pulmonary involvement of IgG4-associated disease is a rare condition with no codified treatment apart from steroid administration. We report here the case of a patient with pulmonary involvement of IgG4-RD successfully managed with Rituximab, in induction and maintenance therapy. This original case could support the use of Rituximab in rare situations of steroid-resistant or steroid-dependent pulmonary IgG4-RD.